GR3004298T3 - - Google Patents
Info
- Publication number
- GR3004298T3 GR3004298T3 GR920400660T GR920400660T GR3004298T3 GR 3004298 T3 GR3004298 T3 GR 3004298T3 GR 920400660 T GR920400660 T GR 920400660T GR 920400660 T GR920400660 T GR 920400660T GR 3004298 T3 GR3004298 T3 GR 3004298T3
- Authority
- GR
- Greece
- Prior art keywords
- relates
- compounds
- leukotrienes
- sulfinyl
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP87309553A EP0313697B1 (en) | 1987-10-29 | 1987-10-29 | Leukotriene antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3004298T3 true GR3004298T3 (el) | 1993-03-31 |
Family
ID=8198080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR920400660T GR3004298T3 (el) | 1987-10-29 | 1992-04-08 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0313697B1 (el) |
JP (1) | JPH01135762A (el) |
AT (1) | ATE73132T1 (el) |
AU (1) | AU610528B2 (el) |
DE (1) | DE3777184D1 (el) |
ES (1) | ES2033322T3 (el) |
GR (1) | GR3004298T3 (el) |
ZA (1) | ZA878085B (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4954513A (en) * | 1988-12-23 | 1990-09-04 | Smithkline Beecham Corporation | Leukotriene antagonists |
CA2018437A1 (en) * | 1989-06-14 | 1990-12-14 | James Simpson Frazee | Leukotriene antagonists |
HU9401975D0 (en) * | 1990-08-01 | 1994-09-28 | Smithkline Beecham Corp | New intermediates for producing 2 -hydroxy-3-sulfido-3-phenyl-propionic acids |
ZW13191A1 (en) * | 1990-09-21 | 1992-02-05 | Smithkline Beecham Corp | Crystallization of optical isomers of leukotriene antagonists |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4513005A (en) * | 1981-06-18 | 1985-04-23 | Lilly Industries Limited | SRS-A antagonists |
GB8320943D0 (en) * | 1983-08-03 | 1983-09-07 | Lilly Industries Ltd | Organic compounds |
US4755524A (en) * | 1986-01-31 | 1988-07-05 | G. D. Searle & Co. | Novel phenolic thioethers as inhibitors of 5-lipoxygenase |
-
1987
- 1987-10-27 AU AU80171/87A patent/AU610528B2/en not_active Expired
- 1987-10-28 ZA ZA878085A patent/ZA878085B/xx unknown
- 1987-10-29 DE DE8787309553T patent/DE3777184D1/de not_active Expired - Lifetime
- 1987-10-29 JP JP62274589A patent/JPH01135762A/ja active Pending
- 1987-10-29 AT AT87309553T patent/ATE73132T1/de not_active IP Right Cessation
- 1987-10-29 ES ES198787309553T patent/ES2033322T3/es not_active Expired - Lifetime
- 1987-10-29 EP EP87309553A patent/EP0313697B1/en not_active Expired - Lifetime
-
1992
- 1992-04-08 GR GR920400660T patent/GR3004298T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0313697B1 (en) | 1992-03-04 |
ZA878085B (en) | 1988-06-27 |
ES2033322T3 (es) | 1993-03-16 |
AU8017187A (en) | 1989-04-27 |
ATE73132T1 (de) | 1992-03-15 |
JPH01135762A (ja) | 1989-05-29 |
DE3777184D1 (de) | 1992-04-09 |
AU610528B2 (en) | 1991-05-23 |
EP0313697A1 (en) | 1989-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0397697A4 (en) | Quinoline derivatives as antagonists of leukotriene d 4? | |
IL110031A (en) | Phenyl heterocycles their manufacture and pharmaceutical compositions containing them | |
IL99538A0 (en) | Fibrinogen receptor antagonists and pharmaceutical compositions containing them | |
IL101779A0 (en) | Fibrinogen receptor antagonists and pharmaceutical compositions containing them | |
PL262105A1 (en) | The method of manufacture of new derivatives of benzimidazole | |
NL930095I1 (nl) | Aromatische heterocyclische esters van steroïden de bereiding daarvan en farmaceutische composities die deze verbindingen bevatten | |
HUT56379A (en) | Process for producing a-norsteroid-3-carboxylic acid derivatives and compositions comprising such compounds | |
IL97025A0 (en) | 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them | |
PL290758A1 (en) | Method of obtaining novel heterocyclene compounds | |
PH25313A (en) | Carboxylic acid derivatives, pharmaceutical compositions containing them | |
IL62198A0 (en) | 3,4,5-trihydroxypiperidine compounds,their production and pharmaceutical compositions containing them | |
FI945975A (fi) | Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
MA21902A1 (fr) | Procede pour la preparation de peptitides hemoregulateurs et des compositions pharmaceutiques les comtenant . | |
NO161492C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-cyklopropyl-6-fluor-1,4-dihydro-4-okso-7-(4-(oksoalkyl)-1-piperazinyl)-3-kinolinkarboksylsyre. | |
ZA886097B (en) | Pharmaceutical composition for the treatment of psoriasis | |
IL79910A (en) | 5,7-dihydro-6-(thi)oxopyrrolo(2,3-f)benzimidazole,-benzothiazole and-benzoxazoles,6-imines thereof,their preparation and pharmaceutical compositions containing them | |
SE8600658D0 (sv) | Novel composition of matter | |
ZA878085B (en) | Leukotriene antoganists | |
SE8604838L (sv) | Farmaceutiska kompositioner | |
ES2053808T3 (es) | Nuevos compuestos azolicos. | |
ES2044422T3 (es) | Composiciones farmaceuticas conteniendo acido 1-isopropildihidrolisergico. | |
IT9021967A0 (it) | Composizioni farmaceutiche contenenti acido 2-(2-pirrolidon-5-carbonilamido)-3-mercaptopropionico, per il trattamento di malattie connesse auna carenza di glutatione | |
EP0337765A3 (en) | Acylsulfonamide derivatives of alpha-carbocyclyltoluic acids used as leukotriene antagonists |